Limited human observations corroborate a favorable short-term tolerability profile, usually involving mild, transient reactions such as localized injection-site irritation or temporary gastrointestinal discomfort
Because Epithalon influences cellular processes, medical supervision is essential to ensure appropriate use and monitor for any individual sensitivities
The statements made on this website have not been evaluated by the US Food and Drug Administration
While these represent uncontrolled single-person reports rather than systematic evidence, they align with the preclinical research findings
RenoV is helpful for treating: Tendon and ligament injuries Joint disease Non-healing wounds Corneal ulcers Key benefits of this therapy include: Immediate availabilityno need to collect blood or stem cells from the injured horse Minimally invasive with a single injection treatment Faster pain relief and reduced inflammation within 3-7 days For more information about RenoV, listen to our podcast
Consistency across vial sizes reduces confusion when you switch between them